SPLENDRIS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SPLENDRIS Trademark

Serial Number: 90389507 • Registration: 6559649

SPLENDRIS is a trademark filed by SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. on December 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (10 trademarks)

37F, Main Tower, Lvjing Plaza,
Futian Dist. Shenzhen 518040 , CN

Entity Type: 99

Trademark Details

Filing Date

December 17, 2020

Registration Date

November 16, 2021

Published for Opposition

August 31, 2021

Goods & Services

Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemico-pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicated Troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medicinal herbal preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases, Pharmaceutical preparations for the treatment of heart rhythm disorders, Synthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical use, namely, beverages and food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, mineral food-supplements used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes, namely, Pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 31, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 31, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 11, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 16, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 16, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 11, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2021 NWOS
NEW APPLICATION ENTERED
Dec 21, 2020 NWAP